Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease
in young children and a substantial contributor to respiratory tract disease throughout life …

Respiratory syncytial virus (RSV) is the most important cause of viral lower respiratory tract
illness (LRI) in infants and children worldwide and causes significant LRI in the elderly and …

Although respiratory syncytial virus (RSV) causes severe lower respiratory tract infection in
infants and adults at risk, no RSV vaccine is currently available. In this report, efforts toward …

Respiratory syncytial virus is the major respiratory pathogen of infants and children
worldwide. Currently, there is no effective vaccine to protect against respiratory syncytial …

Respiratory syncytial virus (RSV) is the most common cause of serious acute lower
respiratory illness in infants and young children and a significant cause of disease burden in …

Live-attenuated respiratory syncytial virus (RSV) vaccines offer several advantages for
immunization of infants and young children:(1) they do not cause vaccine-associated …

Introduction: Respiratory syncytial virus (RSV) causes high morbidity and mortality rates
among infants, young children, and the elderly worldwide. Unfortunately, a safe and effective …

Abstracts Purpose of Review Respiratory syncytial virus (RSV) is a global human pathogen
responsible for lower respiratory tract infections (LRTI). While RSV infection is innocuous in …

Introduction: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract
infection in infants and elderly and to date, there is no safe or effective vaccine against RSV …

Over fifty years have passed since the identification of respiratory syncytial virus (RSV) as an
important pediatric pathogen. However, an effective vaccine is still lacking. Immunization …